Licensed vaccine
Cervarix
FDA-licensed vaccine · GlaxoSmithKline Biologicals · STN BL 125259
Key facts
| Trade name | Cervarix |
|---|---|
| Proper name | Human Papillomavirus Bivalent (Types 16, 18) Vaccine, Recombinant |
| Manufacturer | GlaxoSmithKline Biologicals |
| Submission tracking number (STN) | BL 125259 |
| FDA product areas | Biologics |
| Recent FDA documents | Approval History, Letters, Reviews, and Related Documents - Cervarix, Package Insert & Patient Information- Cervarix, Supporting Documents older than three years - Cervarix |
| FDA page updated | Oct 25, 2019 |
| FDA product page | fda.gov |
At a glance
- None FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: